Africa has been at the back of the queue for COVID-19 vaccines compared to much of the rest of the world, largely because most of the vaccines are made by Western manufacturers. A small biotech ...

In 2021, with the COVID-19 pandemic in full swing, BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) were the darlings of the pharma and biotech worlds. The two mRNA therapy developers created COVID ...

With the validation of the SARS-CoV-2 mRNA vaccines on the global stage, mRNA vaccines and therapeutics are taking the front seat of many biopharma development pipelines. There is an ever-increasing ...

Years from now, when we look back on today’s vaccine development scene, we might say it was almost as consequential as the transition from variolation to vaccination. Variolation, an ancient method, ...

WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently ...

STONY BROOK, NY / ACCESSWIRE / November 9, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it has ...

BUFFALO, N.Y. – A chance meeting at a photocopier. The promise of a safer way to vaccinate. Unexpected calamities in the lab. Finally, a breakthrough and a major publication, only to be met with … ...

Even after a promising experiment sparked expectations for the potential of messenger RNA (mRNA) vaccines, one of the field's early proponents now warns that the treatments have limitations when it ...